A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

Blood Cancer Journal, 2026

Firestone R., Simhal A., Akhlaghi T., Oh J., McAvoy D., Maclachlan K., Garces J., Mailankody S., Hassoun H., Shah U., Korde N., Tan C., Rajeeve S., Hashmi H., Lesokhin A., Hosszu K., Maura F., Deasy J., Usmani S., Hultcrantz M.